CLINICAL_TRIALS trial_result · 2014-08-04

Clinical Trial Update: A Rollover Study For Subjects Discontinuing From UK-453,061 Studies For The Treatment Of HIV-1 [Phase 2]

Pfizer conducted a Phase 2 rollover study of UK-453,061 for HIV-1 that was terminated, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Pfizer | Conditions: HIV-1 | Phase 2 | Status: TERMINATED | Results posted: 2014-08-04